Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADA | P00813 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | DPP4 | P27487 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.60 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.60 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.60 |
| ▸ | GAPDH | P04406 | 1/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.60 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.60 |
| ▸ | STAT6 | P42226 | 1/20 | 0.60 |
| ▸ | PI4KA | P42356 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.60 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nebularine SCHEMBL9644429 | 1.00 | ADA (0.65) | ADAKDM4EPKMDPP4MEN1 | |
| Nebularine SCHEMBL29799158 | 1.00 | ADA (0.65) | ADAKDM4EPKMDPP4MEN1 | |
| Nebularine SCHEMBL93409 | 1.00 | ADA (0.65) | ADAKDM4EPKMDPP4MEN1 | |
| Nebularine SCHEMBL1894168 | 1.00 | ADA (0.65) | ADAKDM4EPKMDPP4MEN1 | |
| Nebularine SCHEMBL745560 | 1.00 | ADA (0.65) | ADAKDM4EPKMDPP4MEN1 | |
| Nebularine SCHEMBL10666450 | 1.00 | ADA (0.65) | ADAKDM4EPKMDPP4MEN1 | |
| Nebularine SCHEMBL27552329 | 1.00 | ADA (0.65) | ADAKDM4EPKMDPP4MEN1 | |
| Nebularine SCHEMBL29362246 | 1.00 | ADA (0.65) | ADAKDM4EPKMDPP4MEN1 | |
| SCHEMBL25170484 | 0.99 | ADA (0.64) | ADAKDM4EPKMDPP4MEN1 | |
| Nebularine SCHEMBL8895399 | 0.99 | ADA (0.64) | ADAKDM4EPKMDPP4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090318556-A1 | BIOMARKERS FOR DETECTING RADIATION EXPOSURE: METHODS AND USES THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2009-12-24 | — | — | US | claimed |
| CN-1612739-A | Method for treating or preventing inflammatory diseases | INSPIRE PHARMACEUTICALS INC (US) | 2005-05-04 | — | — | CN | claimed |
| EP-0986396-A4 | PRION PROTEIN MODULATOR FACTOR (PPMF) AND PRION RESISTANT ANIMALS | UNIV CALIFORNIA (US) | 2003-05-02 | — | — | EP | claimed |
| US-6500652-B2 | OLIGONUCLEOTIDE OF >/=4 NUCLEOTIDES THAT HAS A VIRAL NUCLEIC ACID SEQUENCE WHICH INCLUDES THE INITIATION NUCLEOTIDE | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. | 2002-12-31 | — | — | US | claimed |
| US-20020103143-A1 | USE OF NUCLEIC ACID MOLECULES AS ANTIVIRAL AGENTS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. | 2002-08-01 | — | — | US | claimed |
| US-6355472-B2 | ACID PHOSPHATASE | AJINOMOTO CO., INC. (JP) | 2002-03-12 | — | — | US | claimed |
| US-20020004590-A1 | Method for producing nucleoside-5'-phosphate ester | MIHARA YASUHIRO (JP) | 2002-01-10 | — | — | US | claimed |
| US-6207435-B1 | MUTANT ACID PHOSPHATASE HAVING DECREASED MICHAELIS CONSTANT FOR A NUCLEOSIDE AND/OR INCREASED TEMPERATURE STABILITY; FOR EFFICIENT PHOSPHORYLATION OF NUCLEOSIDES TO PRODUCE NUCLEOTIDES | AJINOMOTO CO., INC. (JP) | 2001-03-27 | — | — | US | claimed |
| EP-1052265-A1 | PROCESS FOR PRODUCING NUCLEOSIDE DERIVATIVES | Ajinomoto Co., Inc. (JP) | 2000-11-15 | — | — | EP | claimed |
| EP-0986396-A1 | PRION PROTEIN MODULATOR FACTOR (PPMF) AND PRION RESISTANT ANIMALS | The Regents of the University of California (US) | 2000-03-22 | — | — | EP | claimed |
| US-6015697-A | ECONOMICAL AND EFFICIENT PROCESS BY REACTING A NUCLEOSIDE WITH A PHOSPHATE DONOR GROUP IN PRESENCE OF MUTANT ACID PHOSPHATASE WITH DECREASED MICHAELIS CONSTANT FOR NUCLEOSIDE OR INCREASED TEMPERATURE STABILITY | AJINOMOTO CO., INC. (JP) | 2000-01-18 | — | — | US | claimed |
| WO-1999049031-A1 | USE OF NUCLEIC ACID MOLECULES AS ANTIVIRAL AGENTS | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. (US) | 1999-09-30 | — | — | WO | claimed |
| WO-1998055132-A1 | PRION PROTEIN MODULATOR FACTOR (PPMF) AND PRION RESISTANT ANIMALS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-12-10 | — | — | WO | claimed |
| EP-4403042-A2 | FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME | Mars, Incorporated (US) | 2024-07-24 | — | — | EP | disclosed |
| EP-3229612-B1 | USE OF FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS INC (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-1992012718-A1 | ADENOSINE KINASE INHIBITORS | GENSIA, INC. (US) | 1992-08-06 | — | — | WO | disclosed |
| US-4016262-A | ANTILIPOLYTIC, HYPERLIPEMIA, ANTICHOLESTEROL AGENTS | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1977-04-05 | — | — | US | disclosed |
| US-3988317-A | ANTICHOLESTEROL AGENTS | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1976-10-26 | — | — | US | disclosed |
| US-3932656-A | SYNTHETIC POLYMER, PROSTAGLANDIN | ALZA CORPORATION (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318556-A1 | BIOMARKERS FOR DETECTING RADIATION EXPOSURE: METHODS AND USES THEREOF | OGG1, UNG, HPRT1 | ADA 777/4885KDM4E 4016/4885PKM 4682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.